Results 1 to 10 of about 2,966,894 (235)

Non-mammalian models in behavioral neuroscience: consequences for biological psychiatry. [PDF]

Front Behav Neurosci, 2015
Current models in biological psychiatry focus on a handful of model species, and the majority of work relies on data generated in rodents. However, in the same sense that a comparative approach to neuroanatomy allows for the identification of patterns of
Maximino C, Silva RX, da Silva Sde N, Rodrigues Ldo S, Barbosa H, de Carvalho TS, Leão LK, Lima MG, Oliveira KR, Herculano AM.   +9 more
europepmc   +4 more sources

Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce [PDF]

World Journal of Biological Psychiatry, 2022
Objectives The therapeutic use of nutrient-based ‘nutraceuticals’ and plant-based ‘phytoceuticals’ for the treatment of mental disorders is common; however, despite recent research progress, there have not been any updated global clinical guidelines ...
Jerome Sarris, Arun Ravindran, Lakshmi N. Yatham, Wolfgang Marx, Julia J. Rucklidge, Roger S. McIntyre, Shahin Akhondzadeh, Francesco Benedetti, Constanza Caneo, Holger Cramer, Lachlan Cribb, Michael de Manincor, Olivia Dean, Andréa Camaz Deslandes, Marlene P. Freeman, Bangalore N. Gangadhar, Brian H. Harvey, Siegfried Kasper, James Lake, Adrian L. Lopresti, Lin Lu, Najwa‐Joelle Metri, David Mischoulon, Chee H. Ng, Daisuke Nishi, Roja Rahimi, Soraya Seedat, Justin Sinclair, Kuan‐Pin Su, Zhang‐Jin Zhang, Michael Berk   +30 more
openalex   +2 more sources

The World Federation of Societies of Biological Psychiatry guidelines on the assessment and pharmacological treatment of compulsive sexual behaviour disorder. [PDF]

Dialogues Clin Neurosci, 2022
Objectives The current guidelines aim to evaluate the role of pharmacological agents in the treatment of patients with compulsive sexual behaviour disorder (CSBD). They are intended for use in clinical practice by clinicians who treat patients with CSBD.
Turner D, Briken P, Grubbs J, Malandain L, Mestre-Bach G, Potenza MN, Thibaut F.   +6 more
europepmc   +2 more sources

Biological Psychiatry is Dead, Long Live Biological Psychiatry! [PDF]

Clin Neuropsychiatry, 2022
The failure of biological psychiatry to deliver on its promises of enlightening the origin of psychiatric disorders and optimizing their treatment is due to invalid theoretical postulates that derive from an outdated conceptualization of human biology ...
Troisi A.
europepmc   +2 more sources

Unconsidered issues of measurement noninvariance in biological psychiatry: A focus on biological phenotypes of psychopathology. [PDF]

Mol Psychiatry, 2022
There is increasing appreciation that certain biological processes may not be equally related to all psychiatric symptoms in a given diagnostic category.
Moriarity DP, Joyner KJ, Slavich GM, Alloy LB.   +3 more
europepmc   +2 more sources

Clinical guidelines for the use of lifestyle-based mental health care in major depressive disorder: World Federation of Societies for Biological Psychiatry (WFSBP) and Australasian Society of Lifestyle Medicine (ASLM) taskforce. [PDF]

World J Biol Psychiatry, 2023
Objectives The primary objectives of these international guidelines were to provide a global audience of clinicians with (a) a series of evidence-based recommendations for the provision of lifestyle-based mental health care in clinical practice for ...
Marx W, Manger SH, Blencowe M, Murray G, Ho FY, Lawn S, Blumenthal JA, Schuch F, Stubbs B, Ruusunen A, Desyibelew HD, Dinan TG, Jacka F, Ravindran A, Berk M, O'Neil A.   +15 more
europepmc   +2 more sources

Messaging in Biological Psychiatry: Misrepresentations, Their Causes, and Potential Consequences. [PDF]

Harv Rev Psychiatry, 2020
Most experts in the field of psychiatry recognize that neuroscience advances have yet to be translated into clinical practice. The main message delivered to laypeople, however, is that mental disorders are brain diseases cured by scientifically designed ...
Dumas-Mallet E, Gonon F.
europepmc   +2 more sources

Clinical guidelines for the management of treatment-resistant depression: French recommendations from experts, the French Association for Biological Psychiatry and Neuropsychopharmacology and the fondation FondaMental. [PDF]

BMC Psychiatry, 2019
BackgroundClear guidance for successive antidepressant pharmacological treatments for non-responders in major depression is not well established.MethodBased on the RAND/UCLA Appropriateness Method, the French Association for Biological Psychiatry and ...
Bennabi D, Charpeaud T, Yrondi A, Genty JB, Destouches S, Lancrenon S, Alaïli N, Bellivier F, Bougerol T, Camus V, Dorey JM, Doumy O, Haesebaert F, Holtzmann J, Lançon C, Lefebvre M, Moliere F, Nieto I, Rabu C, Richieri R, Schmitt L, Stephan F, Vaiva G, Walter M, Leboyer M, El-Hage W, Llorca PM, Courtet P, Aouizerate B, Haffen E.   +29 more
europepmc   +2 more sources

Clinical guidelines for the management of depression with specific comorbid psychiatric conditions French recommendations from experts (the French Association for Biological Psychiatry and Neuropsychopharmacology and the fondation FondaMental). [PDF]

BMC Psychiatry, 2019
BackgroundRecommendations for pharmacological treatments of major depression with specific comorbid psychiatric conditions are lacking.MethodThe French Association for Biological Psychiatry and Neuropsychopharmacology and the fondation FondaMental ...
Bennabi D, Yrondi A, Charpeaud T, Genty JB, Destouches S, Lancrenon S, Allaili N, Bellivier F, Bougerol T, Camus V, Doumy O, Dorey JM, Haesebaert F, Holtzmann J, Lançon C, Lefebvre M, Moliere F, Nieto I, Rabu C, Richieri R, Schmitt L, Stephan F, Vaiva G, Walter M, Leboyer M, El-Hage W, Aouizerate B, Haffen E, Llorca PM, Courtet P.   +29 more
europepmc   +2 more sources

Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry [PDF]

World Journal of Biological Psychiatry, 2017
In the 12 years since the publication of the first Consensus Paper of the WFSBP on biomarkers of neurodegenerative dementias, enormous advancement has taken place in the field, and the Task Force takes now the opportunity to extend and update the ...
Piotr Lewczuk, Peter Riederer, Sid E. O’Bryant, Marcel M. Verbeek, Bruno Dubois, Pieter Jelle Visser, K. A. Jellinger, Sebastiaan Engelborghs, Alfredo Ramı́rez, Lucilla Parnetti, Clifford R. Jack, Charlotte E. Teunissen, Harald Hampel, Alberto Lleó, Frank Jessen, Lidia Glodzik, Mony J. de Leon, Anne M. Fagan, José Luís Molinuevo, Willemijn J. Jansen, Bengt Winblad, Leslie M. Shaw, Ulf Andréasson, Markus Otto, Brit Mollenhauer, Jens Wiltfang, Martin R. Turner, Inga Zerr, Ron Handels, Alexander G. Thompson, Gunilla Johansson, Natalia Ermann, John Q. Trojanowski, Ilker Karaca, Holger Wagner, Patrick Oeckl, Linda van Waalwijk van Doorn, Maria Bjerke, Dimitrios Kapogiannis, H. Bea Kuiperij, Lucia Farotti, Yi Li, Brian A. Gordon, Stéphane Epelbaum, Stephanie J. B. Vos, Catharina J.M. Klijn, William E. Van Nostrand, Carolina Minguillón, Matthias Schmitz, Carla Gallo, Andrea Lopez Mato, Florence Thibaut, Simone Lista, Daniel Alcolea, Henrik Zetterberg, Kaj Blennow, Johannes Kornhuber   +56 more
openalex   +2 more sources